SLXN

Silexion Therapeutics Corp - Ordinary Shares (SLXN)

About Silexion Therapeutics Corp - Ordinary Shares (SLXN)

Silexion Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery and development of treatments for KRAS-driven cancers. The company was founded on November 30, 2008 and is headquartered in in Modiin, Israel.

Details

Daily high

$2.15

Daily low

$2.07

Price at open

$2.14

52 Week High

$51.75

52 Week Low

$1.65

Market cap

6.6M

Dividend yield

0.00%

Volume

38,246

Avg. volume

52,125

P/E ratio

-.08

Silexion Therapeutics Corp - Ordinary Shares News